The management of Castleman disease-Reference-Cited by-同舟云学术

The management of Castleman disease

Published:2021-08-02 Issue:3 Volume:195 Page:328-337
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Lomas Oliver C.¹^ORCID,Streetly Matthew²³,Pratt Guy⁴^ORCID,Cavet Jim⁵,Royston Daniel⁶⁷,Schey Stephen⁸⁹,Ramasamy Karthik¹⁷¹⁰^ORCID,

Affiliation:

1. Department of Clinical Haematology Oxford University Hospitals NHS Foundation Trust OxfordUK

2. Guys and St Thomas’ NHS Foundation Trust LondonUK

3. Kings College Hospital NHS Foundation Trust LondonUK

4. Department of Haematology University Hospitals Birmingham NHS Foundation BirminghamUK

5. The Christie NHS Foundation Trust ManchesterUK

6. Department of Cellular Pathology Oxford University Hospitals NHS Foundation Trust OxfordUK

7. Radcliffe Department of Medicine University of Oxford OxfordUK

8. King’s College University of London LondonUK

9. Department of Haematology King’s College Hospital LondonUK

10. NIHR Oxford Biomedical Research Centre Oxford University NHS Foundation Trust Oxford UK

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.17688

Reference65 articles.

1. Diagnosis of Castleman Disease

2. Use of a claims database to characterize and estimate the incidence rate for Castleman disease

3. Office for National Statistics.Projected UK Adult Population2018. Available from:https://www.ons.gov.uk/aboutus/transparencyandgovernance/freedomofinformationfoi/projectedukadultpopulationfor2018.

4. The clinical spectrum of Castleman's disease

5. The full spectrum of Castleman disease: 273 patients studied over 20 years

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A challenging diagnosis of idiopathic multicentric Castleman disease with complex systemic presentation: A case report;Clinical Case Reports;2023-10

2. The experience of diagnosis and treatment for TAFRO syndrome;Annals of Hematology;2023-09-15

3. Transformation of HHV‐8‐negative idiopathic multicentric Castleman disease into diffuse large B‐cell lymphoma: A case report from Nepal;Clinical Case Reports;2023-09

4. Unmet Clinical Needs in the Management of Idiopathic Multicentric Castleman Disease: A Consensus-based Position Paper From an ad hoc Expert Panel;HemaSphere;2023-05-23

5. Castleman’s disease: A report of two cases at a tertiary hospital in Northern Tanzania;SAGE Open Medical Case Reports;2023-01